An overview of sexually transmitted diseases. Part I

Journal of the American Academy of Dermatology

Volumn 41, Issue 4, 1999, Pages 511-529

  Brown, T J ^a   Yen Moore, A ^a   Tyring, S K ^a  

^a UTMB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ACICLOVIR; AZITHROMYCIN; CEFOTAXIME; CEFTIZOXIME; CEFTRIAXONE; CIPROFLOXACIN; COTRIMOXAZOLE; DOXYCYCLINE; ERYTHROMYCIN; FAMCICLOVIR; OFLOXACIN; PENICILLIN G; SPECTINOMYCIN;

CHLAMYDIASIS; CLINICAL FEATURE; FEVER; GENITAL HERPES; GONORRHEA; HERXHEIMER REACTION; HUMAN; HUMAN TISSUE; INTRAMUSCULAR DRUG ADMINISTRATION; INTRAVENOUS DRUG ADMINISTRATION; LYMPHOGRANULOMA VENEREUM; MYALGIA; PRIORITY JOURNAL; REVIEW; SEXUALLY TRANSMITTED DISEASE; SYPHILIS; ULCUS MOLLE; UNITED STATES;

EID: 0032852053     PISSN: 01909622     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0190-9622(99)80045-0     Document Type: Article

References (155)

1. Division of STD Prevention Sexually Transmitted Disease Surveillance 1997. US Department of Health and Human Services, Public Health Service September 1998 Centers for Disease Control Atlanta
2. Primary and secondary syphilis—United States, 1997 MMWR Morb Mortal Wkly Rep 47 1998 493 497
3. Thomas DL Quinn TC Serologic testing for sexually transmitted diseases Infect Dis Clin North Am 7 1993 793
4. Löwhagen GB Syphilis: test procedures and therapeutic strategies Semin Dermatol 9 1990 152 159
5. Fiumara NJ The diagnosis and treatment of infectious syphilis Compr Ther 21 1995 639 644
6. Buntin DM Rosen T Lesher JL Plotnick H Brademas ME Berger TG Sexually transmitted diseases: bacterial infections J Am Acad Dermatol 25 1991 287 299
7. von Werssowetz AJ The incidence of infection in contacts of early syphillis J Vener Dis Int 29 1948 132 137
8. Moore MB Price EV Knox JM Elgin LW Epidemiologic treatment of contacts of infectious syphilis Public Health Rep 78 1963 966 970
9. Schrijvers D Josse R Trebucq A Dupont A Cheringou H Larouzé B Transmission of syphilis between sexual partners in Gabon Genitourin Med 65 1989 84 85
10. Chapel TA Primary and secondary syphilis Cutis 33 1984 47 53
11. Schober PC Gabriel G White P Felton WF Thin RN How infectious is syphilis Br J Vener Dis 59 1983 217 219
12. Hook EW Marra CM Acquired syphilis in adults N Engl J Med 326 1992 1060 1069
13. Martin DH Mroczkowski TF Dermatologic manifestations of sexually transmitted diseases other than HIV Infect Dis Clin North Am 8 1994 533 582
14. Johnson PC Farnie MA Testing for syphilis Dermatol Clin 12 1994 9 17
15. McDonald LL Stites PC Buntin DM Sexually transmitted diseases update Dermatol Clin 15 1997 221 232
16. Goens JL Janniger CK deWolf K Dermatologic and systemic manifestations of syphilis Am Fam Physician 50 1994 1013 1020
17. Hutchinson CM Hook EW Syphilis in adults Med Clin North Am 74 1990 1389 1416
18. Mindel A Tovey SJ Timmins DJ Williams P Primary and secondary syphilis, 20 years' experience. 2. Clinical features Genitourin Med 65 1989 1 3
19. Rolfs RT Treatment of syphilis, 1993 Clin Infect Dis 20 suppl 1 1995 S23 S38
20. Thomas DL Quinn TC Serologic testing for sexually transmitted diseases Infect Dis Clin North Am 7 1993 793
21. Cummings MC Lukehart SA Marra C Comparison of methods for the detection of Treponema pallidum in lesions of early syphilis Sex Transm Dis 23 1996 366 369
22. Jethwa HS Schmitz JL Dallabetta G Comparison of molecular and microscopic techniques for detection of Trepnema pallidum J Clin Microbiol 33 1995 180 183
23. Zoechling N Schluepen EM Soyer HP Kerl H Volkenandt M Molecular detection of Treponema pallidum in secondary and tertiary syphilis Br J Dermatol 136 1997 683 686
24. Centers for Disease Control and Prevention 1998 Guidelines for treatment of sexually transmitted diseases MMWR 47 No. RR-1 1998 18 49
25. Centers for Disease Control and Prevention 1998 Guidelines for treatment of sexually transmitted diseases MMWR 47 No. RR-1 1998 64 65
26. Al-Suleiman SA Grimes EM Jonas HS Disseminated gonococcal infections Obstet Gynecol 61 1983 48 51
27. Silva J Wilson K Disseminated gonococcal infections (DGI) Cutis 24 1979 601 606
28. English JC Monk JS Gonococcal dermatitis-arthritis syndrome Am Fam Physician 34 1986 77 79
29. Klebanoff SJ Smith DC Peroxidase-mediated antimicrobial activity of rat uterine fluid Gynecol Invest 1 1970 21 30
30. Abu-Nassar H Hill N Fred HL Cutaneous manifestations of gonococcemia Arch Intern Med 112 1963 731 737
31. Buntin DM Cutaneous features of sexually transmitted diseases: recognition and treatment Postgard Med 78 1985 121 128
32. Brenner S Dorfman B Krakowski A Hazaz B Yaron M Michaeli D An unusual pattern of arthritis dermatitis syndrome Cutis 32 1983 175 177
33. Holmes KK Counts GW Beaty HN Disseminated gonococcal infection Ann Intern Med 74 1971 979 993
34. Kraus SJ Complications of gonococcal infection Med Clin North Am 56 1972 1115 1125
35. Schulte JM Martich FA Schmid GP Chancroid in the United States 1981–1990: evidence for underreporting of cases MMWR 41 No. SS-3 1992 57 61
36. Goens JL Schwartz RA de Wolf K Mucocutaneous manifestations of chancroid, lymphogranuloma venereum and granuloma inguinale Am Fam Physician 49 1994 415 425
37. Boyd AS Clinical efficacy of antimicrobial therapy in Haemophilus ducreyi infections Arch Dermatol 125 1989 1399 1405
38. DiCarlo RP Armentor BS Martin DH Chancroid epidemiology in New Orleans men J Infect Dis 172 1995 446 452
39. Marrazzo JM Handsfield HH Chancroid: new developments in an old disease Curr Top Infect Dis 15 1995 129 152
40. Jones CC Rosen T Cultural diagnosis of chancroid Arch Dermatol 127 1991 1823 1837
41. Rosen T Dhir A Chancroid, granuloma inguinale, and lymphogranuloma venereum Arndt KA Cutaneous medicine and surgery, an integrated program in dermatology 1996 WB Saunders Philadelphia 973 982
42. Jones CC Rosen T Clarridge J Collins S Chancroid: results from an outbreak in Houston, Texas South Med J 83 1990 1384 1399
43. Chapel TA Brown WJ Jeffries C Stewart JA How reliable is the morphological diagnosis of penile ulcerations? Sex Transm Dis 4 1977 150 152
44. Sturm AW Stolting GJ Cormane RH Zanen HC Clinical and microbiological evaluation of 46 episodes of genital ulceration Genitourin Med 63 1987 98 101
45. Werman BS Herskowitz LJ Olansky S Kleris G Sottnek FO A clinical variant of chancroid resembling granuloma inguinale Arch Dermatol 119 1983 890 894
46. Schmid GP Approach to the patient with genital ulcer disease Med Clin North Am 74 1990 1559 1572
47. Strakosch EA Kendall HW Craig RM Clinical and laboratory investigation of 370 cases of chancroid J Invest Dermatol 6 1945 95 107
48. Teague O Diebert O The value of the cultural method in the diagnosis of chancroid J Urol 4 1920 543 550
49. Schmid GP Faur YC Valu JA Sikandar SA McLaughlin MM Enhanced recovery of Haemophilus ducreyi from clinical specimens by incubation at 33 versus 355C J Clin Microbiol 33 1995 3257 3259
50. Trees DL Morse SA Chancroid and Haemophilus ducreyi : an update Clin Microbiol Rev 8 1995 357 375
51. Dangor Y Miller SD Koornhof HJ Ballard RC A simple medium for the primary isolation of Haemophilus ducreyi Eur J Clin Microbiol Infect Dis 11 1992 930 934
52. Morse SA Chancroid and Haemophilus ducreyi Clin Microbiol Rev 2 1989 137 157
53. Kraus SJ Diagnosis and management of acute genital ulcers in sexually active patients Semin Dermatol 9 1990 160 166
54. Joseph AK Rosen T Laboratory techniques used in the diagnosis of chancroid, granuloma inguinale, and lymphogranuloma venereum Dermatol Clin 12 1994 1 8
55. Karim QN Finn GY Easmon CSF Rapid detection of Haemophilus ducreyi in clinical and experimental infections using monoclonal antibody Genitourin Med 65 1989 361 365
56. Schalla WO Sanders LL Schmid GP Tam MR Morse SA Use of dot-immunobinding and immunofluorescence assays to investigate clinically suspected cases of chancroid J Infect Dis 153 1986 879 887
57. Perine PL Stamm WE Lymphogranuloma venereum Holmes KK Sparling PF Mårdh PA Sexually transmitted disease 3rd ed 1999 McGraw-Hill New York 423 432
58. Engelkens HJ Stolz E Genital ulcer disease Int J Dermatol 32 1993 169 181
59. Thompson SE Washington AE Epidemiology of sexually transmitted Chlamydia trachomatis infections Epidemiol Rev 5 1983 96 123
60. Schachter J Osoba AO Lymphogranuloma venereum Br Med Bull 39 1983 151 154
61. Schachter J Chlamydial infections N Engl J Med 298 1978 428 435
62. Scieux C Barnes R Bianchi A Casin I Morel P Perol Y Lymphogranuloma venereum: 27 cases in Paris J Infect Dis 160 1989 662 668
63. Kellock DJ Barlow R Suvarna SK Green S Eley A Rogstad KE Lymphogranuloma venereum: biopsy, serology, and molecular biology Genitourin Med 73 1997 399 401
64. Mroczkowski TF Martin DH Genital ulcer disease Dermatol Clin 12 1994 753 764
65. Rothenberg RB Lymphogranuloma venereum Freedberg IM Eisen AZ Wolff K Dermatology in general medicine 5th ed 1999 McGraw-Hill New York 2591 2594
66. Burgoyne RA Lymphogranulma venereum Prim Care 17 1990 153 157
67. Myhre EB Mardh PA Unusual manifestations of Chylamydia trachomatis infections Scand J Infect Dis Suppl 32 1982 122 126
68. Buus DRE Pflugfelder SC Schachter J Lymphogranuloma venereum of 20 years' duration Br J Vener Dis 56 1980 344 346
69. Faro S Lymphogranuloma venereum chancroid and lymphogranuloma inguinale Obstet Gynecol Clin North Am 16 1989 517 530
70. Mittal A Sachdeva KG Monoclonal antibody for the diagnosis of lymphogranuloma venereum: a preliminary report Br J Biomed Sci 50 1993 3 7
71. Chopda NM Desai DC Sawant PD Nanivadekar SA Dave UR Satarkar RP Recta lymphogranuloma venereum in association with rectal adenocarcinoma Indian J Gastroenterol 13 1994 103 104
72. Barnes RC Laboratory diagnosis of human chlamydial infections Clin Microbiol Rev 2 1989 119 136
73. Van Dyck E Piot P Laboratory techniques in the investigation of chancroid, lymphogranuloma venreum, and donovanosis Genitourin Med 68 1992 130 133
74. Allegra F Lymphogranuloma venereum Parish LC Gschnait F Sexually transmitted disease: a guide for clinicians 1989 Springer-Verlag New York 90 104
75. Treharne JD Forsey T Thomas BJ Chlamydial serology Br Med Bull 39 1983 194 200
76. Stephens RS Kuo CC Tam MR Sensitivity of immunofluorescence with monoclonal antibodies for detection of Chlamydia trachomatis inclusions in cell culture J Clin Microbiol 16 1982 4 7
77. Aldridge KE Cammarata C Martin DH Comparison of the in vitro activities of various parenteral and oral antimicrobial agents against endemic Haemophilus ducreyi 3 Antimicrob Agents Chemother 37 1993 1986 1988
78. Parkash S Radhakrishna K Problematic ulcerative lesions in sexually transmitted diseases: surgical managements Sex Transm Dis 13 1986 127 133
79. Richens J The diagnosis and treatment of donovanosis (granuloma inguinale) Genitourin Med 67 1991 441 452
80. Kharsany ABM Hoosen AA Kiepiela P Naicker T Sturm AW Growth and cultural characteristics of Calymmatobacterium granulomatis : the aetiological agent of granuloma inguinale (Donovanosis) J Med Microbiol 46 1997 579 585
81. Hart G Donovanosis Clin Infect Dis 25 1997 24 32
82. Kuberski T Papadimitiou JM Phillips P Ultrastructure of Calymmatobacterium granulomatis in lesions of granuloma inguinale J Infect Dis 142 1980 744 749
83. Lal S Nicholas C Epidemiological and clinical features in 165 cases of granuloma inguinale Br J Vener Dis 46 1970 461 463
84. Packer H Goldberg J Studies of the antigenic relationship of D. granulomatis to members of the tribe Escherichae Am J Syphilis Gonorrhea Vener Dis 34 1950 342 350
85. Serma JS Granuloma venereuma problem in Guntur Indian J Dermatol Venereol Leprol 35 1969 45 52
86. Ramachander M Jayalakshmi S Pankaja P A study of donovanosis in Guntur Indian J Dermatol Venereol Leprol 33 1967 237 241
87. Vimla Bai K Sulibhari DG Shyam Sunder P A study of donovanosis Indian J Dermatol Venereol Leprol 35 1969 45 52
88. Mitchell KM Roberts AN Williams VM Schneider J Donovanosis in Western Australia Genitourin Med 62 1986 191 195
89. Sehgal VN Sharma NL Bhargava NC Nayar M Chandra M Primary extragenital disseminated cutaneous donovanosis Br J Dermatol 101 1979 353 356
90. Packer H Turner HB Dulaney AD Granulorna inguinale of the vagina and cervix uteri with bone metastases JAMA 136 1961 327 329
91. Maddocks I Anders EM Dennis E Donovanosis in Papua New Guinea Br J Vener Dis 52 1976 190 196
92. Brain P Granuloma inguinale with extensive oral involvement S Afr Med J 25 1951 581 582
93. Jennison DB Helwig EB Milstone JH Granuloma inguinale involving buttock and lymph node Arch Dermatol Syphilol 55 1947 342 354
94. Brigden M Guard R Extragenital granuloma inguinale in North Queensland Med J Aust 2 1980 565 567
95. Goldberg J Annamuthodo H Studies on granuloma inguinale. 8. Serological reactivity of sera from patients with carcinoma of penis when tested with Donovania antigens Br J Vener Dis 42 1966 205 209
96. [letter] Kharsany ABM Hoosen AA Kiepiola P Naicker T Sturm AW Culture of Calymmatobacterium granulomatis Clin Infect Dis 22 1996 391
97. Carter J Hutton S Sriprakash KS Culture of the causative organism of Donovanosis ( Calymmatobacterium granulomatis ) in Hep-2 cells J Clin Microbiol 35 1997 2915 2917
98. Paterson DL Disseminated donovanosis (granuloma inguinale) causing spinal cord compression: case report and review of donovanosis involving bone Clin Infect Dis 26 1998 379 383
99. Hacker P Fisher BK Dekoven J Shier RM Granuloma inguinale: three cases diagnosed in Toronto, Canada Int J Dermatol 31 1992 696 699
100. Packer H Dulaney AD Diagnostic tests in granuloma inguinale Am J Syphillis 33 1949 68 75
101. Marmell M Santora E Donovanosis-granuloma inguinale: incidence, nomenclature, and diagnosis Am J Syphillis 34 1950 83 90
102. Kinghorn GR Genital herpes: natural history and treatment of acute episodes J Med Virol suppl 1 1993 33 38
103. Fleming DT McQuillan GM Johnson RE Herpes simplex virus type 2 in the United States, 1976 to 1994 N Engl J Med 337 1997 1105 1111
104. Arvin AM Prober CG Herpes simplex virus type 2: a persistent problem N Engl J Med 337 1997 1158 1159
105. Nahmias AJ Lee FK Beckman-Nahmias S Sero-epidemiological and sociological patterns of herpes simplex virus infection in the world Scand J Infect Dis 69 1990 19 36
106. Oberle MW Rosero-Bixby L Lee FK Sanchez-Braverman M Nahmias AJ Guinan ME Herpes simplex virus type 2 antibodies: high prevalence in monogamous women in Costa Rica Am J Trop Med Hyg 41 1989 224 229
107. Pereira FA Herpes simplex: evolving concepts J Am Acad Dermatol 35 1996 503 520
108. Brugha R Keersmaekers K Renton A Meheus A Genital herpes infection: a review Int J Epidemiol 26 1997 698 709
109. Kinghorn GR Limiting the spread of genital herpes Scand J Infect Dis Suppl 100 1996 20 25
110. Schomogyi M Wald A Corey L Herpes simplex virus-2 infection: An emerging disease? Infect Dis Clin North Am 12 1998 47 61
111. (suppl) Corey L The current trend in genital herpes: progress in prevention Sex Transm Dis 21 1994 S38 S44
112. Kinghorn GR Epidemiology of genital herpes J Int Med Res 22 suppl 1 1994 14A 23A
113. Bryson Y Dillon M Bernstein DI Radolf J Zakowski P Garratty E Risk of acquisition of genital herpes simplex virus type 2 in sex partners of persons with genital herpes: a prospective couple study J Infect Dis 167 1993 942 946
114. Mertz GJ Benedetti J Ashley R Selke SA Corey L Risk factors for the sexual transmission of genital herpes Ann Intern Med 116 1992 197 202
115. Benedetti J Corey L Ashley R Recurrence rates in genital herpes after symptomatic first-episode infection Ann Int Med 121 1994 847 854
116. Koelle DM Benedetti J Langenberg A Corey L Asymptomatic reactivation of herpes simplex virus in women after the first episode of genital herpes Ann Intern Med 116 1992 433 437
117. Lafferty WE Coombs RW Benedetti J Critchlow C Corey L Recurrences after oral and genital herpes simplex virus infection: influence of site of infection and viral type N Engl J Med 316 1987 1444 1449
118. Mertz GJ Schmidt O Jourden JL Frequency of acquisition of first episode genital infection with herpes simplex virus from symptomatic and asymptomatic source contacts Sex Transm Dis 12 1985 33 39
119. Breinig MK Kingsley LA Armstrong JA Freeman DJ Ho M Epidemiology of genital herpes in Pittsburgh: serologic, sexual, and racial correlates of apparent and inapparent herpes simplex infection J Infect Dis 162 1990 299 305
120. Koutsky LA Stevens CE Holmes KK Underdiagnosis of genital herpes by current clinical and viral-isolation procedures N Engl J Med 326 1992 1533 1539
121. Johnson RE Nahmias AJ Magder LS Lee FK Brooks CA Snowden CB A seroepidemiological survey of the prevalence of herpes simplex virus type 2 infection in the United States N Engl J Med 321 1989 7 12
122. Yeager AS Arvin AM Reasons for the absence of a history of recurrent genital infections in mothers of neonates infected with herpes virus Pediatrics 73 1984 188 196
123. Ashley R Cent A Maggs V Nahimias AJ Corey L Inability of enzyme immunoassays to discriminate between infections with herpes simplex virus types 1 and 2 Ann Intern Med 115 1991 520 526
124. Reichman RC Badger GJ Mertz GJ Treatment of recurrent genital herpes simplex infections with acyclovir: a controlled trial JAMA 251 1984 2103 2107
125. Mertz GJ Epidemiology of genital herpes infections Infect Dis Clin North Am 7 1993 825 839
126. Barton SE Munday PE Patel RJ Asymptomatic shedding of herpes simplex virus from the genital tract: uncertainty and its consequences for patient management Int J STD AIDS 7 1996 229 232
127. Langenberg A Benedetti J Jenkins J Ashley R Winter C Corey L Development of clinically recognizable genital lesions among women previously identified as having “asymptomatic” herpes simplex virus type 2 infection Ann Intern Med 110 1989 882 887
128. Corey I Adams HG Brown ZA Holmes KK Genital herpes virus infections: clinical manifestations, course and complications Ann Intern Med 98 1983 958 972
129. Harbour DA Hill TJ Blyth WA Recurrent herpes simplex in the mouse: inflammation in the skin and activation of virus in the ganglia following peripheral stimulation J Gen Virol 64 1983 1491 1498
130. Rooney JF Bryson Y Mannix ML Prevention of ultraviolet-light-induced herpes labialis by sunscreen Lancet 338 1991 1419 1422
131. Wachsman M Aurelian L Burnett JW The prophylactic use of cyclooxygenase inhibitors in recurrent herpes simplex infections Br J Dermatol 123 1990 375 380
132. Baker DA Thomas J Epstein J Possilico D Stone ML The effect of prostaglandins on the multiplication and cell-to-cell spread of herpes simplex virus type 2 in vitro Am J Obstet Gynecol 144 1982 346 349
133. Corey L Homes KK Genital herpes simplex virus infections: current concepts in diagnosis, therapy, and prevention Ann Intern Med 98 1983 973 983
134. Ashley R Laboratory techniques in the diagnosis of herpes simplex infection Genitourin Med 64 1993 174 183
135. Wald A Corey L Cone R Hobson A Davis G Zeh J Frequent genital herpes simplex virus shedding in immunocompetent women: effect of acyclovir treatment J Clin Invest 99 1997 1092 1097
136. DeMiranda P Blum MR Pharmacokinetics of acyclovir after intravenous and oral administration J Antimicrob Chemother 12 suppl B 1983 29 37
137. Bodsworth NJ Crooks RJ Borelli S Valaciclovir versus aciclovir in patient initiated treatment of recurrent genital herpes: a randomised, double blind clinical trial. International Valaciclovir HSV Study Group Genitourin Med 73 1997 110 116
138. Goldberg LH Oral acyclovir for episodic treatment of recurrent genital herpes: efficacy and safety J Am Acad Dermatol 15 1986 256 264
139. Nilsen AE Aasen T Halsos AM Efficacy of oral acyclovir in the treatment of initial and recurrent genital herpes Lancet 2 1982 571 573
140. Salo AP Lassus A Hovi T Fiddian AP Double-blind placebo controlled trial of oral acyclovir in recurrent genital herpes Eur J Sex Transm Dis 1 1983 95 98
141. Tyring SK Advances in the treatment of herpesvirus infection: the role of famciclovir Clin Ther 20 1998 661 670
142. Tyring SK Douglas JM Corey L Spruance SL Esmann J A randomized, placebo-controlled comparison of oral valacyclovir and acyclovir in immunocompetent patients with recurrent genital herpes infections Arch Dermatol 134 1998 185 191
143. Mertz GJ Jones CC Mills J Long-term acyclovir suppression of frequently recurring genital herpes simplex virus infection: a multicenter double-blind trial JAMA 260 1988 201 206
144. Goldberg LH Kaufman R Kurtz Long-term suppression of recurrent herpes with acyclovir: a 5-year benchmark Acyclovir Study Group Arch Dermatol 129 1993 582 587
145. Wald A Zeh J Barnum G Davis LG Corey L Suppression of subclinical shedding of herpes simplex virus type 2 with acyclovir Ann Intern Med 124 1996 8 15
146. Baker DA Long-term suppressive therapy with acyclovir for recurrent genital herpes J Int Med Res 22 suppl 1 1994 24A 32A
147. Mertz GJ Loveless MO Levin MJ Oral famciclovir for suppression of recurrent genital herpes simplex virus infection in women Arch Intern Med 157 1997 343 349
148. Reitano M Tyring S Lang W Valaciclovir for the suppression of recurrent genital herpes simplex virus infection: a large-scale dose range-finding study J Infect Dis 178 1998 603 610
149. Patel R Barton SE Antiviral chemotherapy in genital herpes simplex virus infections Int J STD AIDS 6 1995 320 328
150. Pottage JC Kessler HA Herpes simplex virus resistance to acyclovir: clinical relevance Infect Agents Dis 4 1995 115 124
151. Stanberry LR Herpes: vaccines for HSV Dermatol Clin 16 1998 811 816
152. Burke RL Development of a herpes simplex virus subunit glycoprotein vaccine for prophylactic and therapeutic use J Infect Dis 13 1991 S906 S911
153. Burke RL Goldbeck C Ng P Stanberry L Ott G Van Nest G The influence of adjuvant on the therapeutic efficacy of a recombinant genital herpes vaccine Rev Infect Dis 170 1994 1110 1119
154. Farrell JE McLean CS Harley C Efstathiou S Inglis S Minson AC Vaccine potential of a herpes simplex virus type/mutant with an essential glycoprotein deleted J Virol 68 1994 927 932
155. McLean CS Erturk M Jennings R Protective vaccination against primary and recurrent disease, caused by herpes simplex virus (HSV) type 2 using a genetically disabled HSV-1 J Infect Dis 170 1994 1100 1109